1995 - Member of the National Academy of Sciences
1995 - Promega Biotechnology Research Award, American Society for Microbiology
Larry Gold mainly investigates Systematic evolution of ligands by exponential enrichment, Biochemistry, Nucleic acid, Computational biology and Genetics. His Systematic evolution of ligands by exponential enrichment study is associated with RNA. His work in Biochemistry addresses issues such as Ligand, which are connected to fields such as Molecule.
His Nucleic acid research is multidisciplinary, incorporating perspectives in Polymerase, DNA, Ligand, Nucleotide and Combinatorial chemistry. His Polymerase study incorporates themes from Nucleic acid structure, Transcription, Drug discovery and DNA polymerase. His Computational biology research incorporates themes from Proteomics, Molecular biology, Aptamer, Complementarity and Stereochemistry.
Larry Gold mostly deals with Biochemistry, Nucleic acid, Systematic evolution of ligands by exponential enrichment, Molecular biology and RNA. His Oligonucleotide, Binding site, Tenascin C and Enzyme study, which is part of a larger body of work in Biochemistry, is frequently linked to Identification, bridging the gap between disciplines. His research in Nucleic acid focuses on subjects like Molecule, which are connected to Covalent bond.
He combines subjects such as Computational biology, DNA, Aptamer and Nucleotide with his study of Systematic evolution of ligands by exponential enrichment. His biological study spans a wide range of topics, including Bacteriophage, Transcription, Messenger RNA, Gene and Cell biology. His RNA research integrates issues from Consensus sequence and Virology.
His primary areas of study are Aptamer, Computational biology, Proteomics, Biomarker discovery and Bioinformatics. His Aptamer research is multidisciplinary, relying on both Combinatorial chemistry, Molecule, Nucleic acid and Systematic evolution of ligands by exponential enrichment. Nucleic acid is the subject of his research, which falls under Biochemistry.
His studies in Computational biology integrate themes in fields like Genetics, SELEX Aptamer Technique, Proteomics methods and Human proteome project. His Proteomics research includes elements of Proteome, Disease, Cohort, Pathology and DNA microarray. He has researched Biomarker discovery in several fields, including Multiplex, Microarray, Molecular biology, Serum protein and Lung cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase
Craig Tuerk;Larry Gold.
Aptamer-based multiplexed proteomic technology for biomarker discovery
Larry Gold;Deborah Ayers;Jennifer Bertino;Christopher Bock.
PLOS ONE (2010)
Information content of binding sites on nucleotide sequences
Thomas D. Schneider;Gary D. Stormo;Larry Gold;Andrzej Ehrenfeucht.
Journal of Molecular Biology (1986)
Methods for identifying nucleic acid ligands
Larry Gold;Craig Tuerk.
Nucleic acid ligands
Larry Gold;Craig Tuerk.
Diversity of Oligonucleotide Functions
Larry Gold;Barry Polisky;Olke Uhlenbeck;Michael Yarus.
Annual Review of Biochemistry (1995)
Posttranscriptional regulatory mechanisms in Escherichia coli.
Annual Review of Biochemistry (1988)
Translational Initiation in Prokaryotes
L. Gold;D. Pribnow;T. Schneider;S. Shinedling.
Annual Review of Microbiology (1981)
Aptamers as therapeutic and diagnostic agents
Edward N. Brody;Larry Gold.
Reviews in Molecular Biotechnology (2000)
Use of the ‘Perceptron’ algorithm to distinguish translational initiation sites in E. coli
Gary D. Stormo;Thomas D. Schneider;Larry Gold;Andrzej Ehrenfeucht.
Nucleic Acids Research (1982)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: